What is the diagnosis and treatment for orthostatic hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Orthostatic hypotension should be managed with a combination of lifestyle modifications and pharmacological interventions, prioritizing midodrine and droxidopa as first-line treatments, as recommended by the most recent guidelines 1. To manage orthostatic hypotension, start by implementing lifestyle modifications:

  • Rise slowly from lying or sitting positions
  • Stay well-hydrated by drinking 2-3 liters of water daily
  • Increase salt intake (unless contraindicated by other conditions)
  • Wear compression stockings
  • Avoid alcohol and large meals If symptoms persist, medications may be necessary. First-line pharmacological options include:
  • Midodrine (2.5-10 mg three times daily), an alpha-1 agonist that constricts blood vessels
  • Droxidopa (100-600 mg three times daily) for neurogenic orthostatic hypotension These medications should be taken early in the day to avoid nighttime hypertension, with the last dose at least 3-4 hours before bedtime. Underlying causes should be addressed, such as adjusting medications that may contribute to hypotension (like antihypertensives, antidepressants, or diuretics) 1. Orthostatic hypotension occurs because of inadequate compensatory mechanisms that normally increase vascular tone and heart rate when standing, often due to autonomic nervous system dysfunction, dehydration, medication effects, or aging. Key considerations in treatment include minimizing postural symptoms rather than restoring normotension, and using nonpharmacologic measures in conjunction with pharmacologic interventions 1.

From the FDA Drug Label

Midodrine hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (OH) Because midodrine hydrochloride tablets can cause marked elevation of supine blood pressure (BP>200 mmHg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations

The diagnosis of orthostatic hypotension is not explicitly stated in the provided drug labels. The treatment for orthostatic hypotension includes:

  • Midodrine hydrochloride tablets for symptomatic orthostatic hypotension
  • Non-pharmacologic treatment, such as:
    • Support stockings
    • Fluid expansion
    • Lifestyle alterations Midodrine should be used in patients whose lives are considerably impaired despite standard clinical care 2.

From the Research

Diagnosis of Orthostatic Hypotension

  • Orthostatic hypotension is defined as a decrease in systolic blood pressure of 20 mm Hg or a decrease in diastolic blood pressure of 10 mm Hg within three minutes of standing when compared with blood pressure from the sitting or supine position 3, 4, 5.
  • Symptoms of orthostatic hypotension include dizziness, lightheadedness, blurred vision, weakness, fatigue, nausea, palpitations, and headache 3, 4.
  • Diagnosis is confirmed by performing a bedside simplified Schellong test, which consists of blood pressure and heart rate measurements after five minutes in the supine position and three minutes after moving to a standing position 4.
  • Head-up tilt-table testing can aid in confirming a diagnosis of suspected orthostatic hypotension when standard orthostatic vital signs are nondiagnostic 3, 4.

Treatment of Orthostatic Hypotension

  • Goals of treatment involve improving hypotension without excessive supine hypertension, relieving orthostatic symptoms, and improving standing time 3.
  • Nonpharmacologic treatment should be offered to all patients, including dietary modifications, compression garments, physical maneuvers, and avoiding environments that exacerbate symptoms 3, 4, 5.
  • Pharmacologic therapies proven to be beneficial include fludrocortisone, midodrine, and pyridostigmine 3, 6, 7.
  • First-line medications include midodrine and droxidopa, although fludrocortisone may be used in certain cases 4, 5, 7.
  • Treatment should be individualized according to the severity, underlying cause, 24-hour blood pressure profile, and associated coexisting conditions 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation and management of orthostatic hypotension.

American family physician, 2011

Research

Orthostatic Hypotension: A Practical Approach.

American family physician, 2022

Research

Fludrocortisone for orthostatic hypotension.

The Cochrane database of systematic reviews, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.